Metformin Efficacy and Safety for Gastric Intestinal Metaplasia

PHASE4CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

April 1, 2022

Primary Completion Date

May 31, 2023

Study Completion Date

October 31, 2023

Conditions
Gastric Intestinal Metaplasia
Interventions
DRUG

Metformin

Subjects will be instructed to take one tablet(500mg) of metformin after breakfast every day, and to visit the hospital every 4 weeks for evaluation of the subjective symptoms and for receiving a new supply of medication.

DRUG

Folate

Subjects will be instructed to take one tablet(5mg) of folate three times every day, and to visit the hospital every 4 weeks for evaluation of the subjective symptoms and for receiving a new supply of medication.

Trial Locations (2)

710032

Xijing Hosipital of Digestive Disease, Xi'an

Unknown

Xijing hospital, Xi'an

All Listed Sponsors
lead

Xijing Hospital of Digestive Diseases

OTHER